4-(1,3-Oxazol-2-yl)aniline → HCID 117622969, compound
Reaction equation
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]#[N:24])=[C:6]([C:8]2[C:13]([O:14][CH3:15])=[CH:12][N:11]([CH:16]([CH2:20][CH3:21])[C:17]([OH:19])=O)[C:10](=[O:22])[CH:9]=2)[CH:7]=1.[O:25]1[CH:29]=[CH:28][N:27]=[C:26]1[C:30]1[CH:36]=[CH:35][C:33]([NH2:34])=[CH:32][CH:31]=1>>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:23]#[N:24])=[C:6]([C:8]2[C:13]([O:14][CH3:15])=[CH:12][N:11]([CH:16]([CH2:20][CH3:21])[C:17]([NH:34][C:33]3[CH:32]=[CH:31][C:30]([C:26]4[O:25][CH:29]=[CH:28][N:27]=4)=[CH:36][CH:35]=3)=[O:19])[C:10](=[O:22])[CH:9]=2)[CH:7]=1Participants
3
Procedure
100 mg (0.29 mmol) of 2-[4-(5-chloro-2-cyanophenyl)-5-methoxy-2-oxopyridin-1(2H)-yl]butanoic acid (racemate) and 73 mg (0.43 mmol, 1.5 eq.) of 4-(1,3-oxazol-2-yl)aniline were reacted according to General Method 7. The crude product was purified by normal phase chromatography (mobile phase: dichloromethane/methanol 1-10% mixtures). Yield: 89 mg (63% of theory)
Workup
- customThe crude product was purified by normal phase chromatography (mobile phase: dichloromethane/methanol 1-10% mixtures)
Sources & evidence
- ORD record
- ord-3611fd54748342c38f8716a9ea1de73b
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09434690B2
Reaction notes
Loading…